KEI panel on government funding of COVID drugs and vaccines at the Global Congress on Intellectual Property and the Public Interest

On October 5, 2020, KEI organized a panel about government funding of COVID-19 drugs and vaccines at the Global Congress on Intellectual Property and the Public Interest. Although the full Global Congress event was postponed to the year 2021, the… Continue Reading

KEI written statement at the WHO Executive Board special session: Update on implementation of resolution WHA73.1 (2020) on the COVID-19 response

Knowledge Ecology International (KEI) is an accredited non-state actor at the World Health Organization (WHO). This is our statement at the WHO Executive Board Special Session on the COVID-19 response. https://extranet.who.int/nonstateactorsstatements/print/book/export/html/3916?destination=node/3916 Knowledge Ecology International Meeting: EB Special session on the… Continue Reading

KEI Sues NIH over Improper Withholding of Three FOIA Requests

On September 29, 2020, Knowledge Ecology International (KEI) filed a lawsuit against the National Institutes of Health (NIH) regarding three Freedom of Information Act (FOIA) requests filed by KEI. The complaint filed by KEI requests injunctive, declaratory, and other appropriate… Continue Reading

WIPO Side event: Appraising Progress of WHO’s COVID-19 Technology Access Pool (C-TAP)

DATE: Tuesday, 22 September 2020 TIME: 18:00 CEST to 19:00 CEST CONVENER: Knowledge Ecology International (KEI) REGISTRATION: Please contact thiru [at] keionline.org On occasion of the 61st Series of Meetings of the WIPO General Assembly, Knowledge Ecology International (KEI) is… Continue Reading

Joint letter to WHO formally requesting the R&D Observatory to play a more relevant role in the COVID-19 response

On Friday, 28 August 2020, six groups including Corporación Innovarte, Health Action International, Knowledge Ecology International, Medicines Law & Policy, Pharmaceutical Accountability Foundation, and Wemos wrote a joint letter to the World Health Organization’s (WHO) Chief Scientist, Dr. Soumya Swaminathan,… Continue Reading

BARDA is investigating Moderna’s failures to disclose BARDA funding in patent applications

(More on Moderna here: https://www.keionline.org/moderna) KEI received a letter Dr. Gary Disbrow, the Acting Director of BARDA, just before noon today. BARDA2KEI.Moderna.Patent.Disclosures.20200903 The BARDA investigation follows the announcement on Saturday that DARPA was also investigating DARPA’s failures to disclose DARPA… Continue Reading